Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS

Current Report · Items 5.02, 5.07, 9.01 · 8-K

Lesaka Technologies, Inc.

LSAKNASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security Holders

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Option award to Ali Mazanderani On August 3, 2026, at a special meeting of shareholders (the "Special Meeting") of Lesaka Technologies, Inc. (the "Company"), the shareholders of the Company approved the grant of a stock option ("Option Award") to Mr.…

Filed Aug 3, 2026Accepted Aug 3, 2026, 9:48 AM EDTCIK 1041514Accession 0001062993-26-003974
Share

Company context

Current securities

Historical securities (1)

Recent company filings

  1. ARS filingOct 2, 2026
  2. DEFA14A filingOct 2, 2026
  3. DEF 14A filingOct 2, 2026
  4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 29, 2026
  5. 4 filingSep 17, 2026

Disclosure sections

Items 5.02, 5.07, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Option award to Ali Mazanderani On August 3, 2026, at a special meeting of shareholders (the "Special Meeting") of Lesaka Technologies, Inc. (the "Company"), the shareholders of the Company approved the grant of a stock option ("Option Award") to Mr. Ali Mazanderani, the Company's Executive Chairman, pursuant to a stock option agreement, as further described in the Company's definitive proxy statement for the Special Meeting filed with the Securities and Exchange Commission on July 2, 2026 (the "2026 Proxy Statement"). Below is an overview of the Option Award. Award Terms Details ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Option Award 1,000,000 share options. Equity Type Options to acquire common stock. Exercise Price 1,000,000 share options at an exercise price of US$5.00 per share. Exercise Date Mr. Mazanderani may only exercise the vested Option Award after April 1, 2029. Expiration Date April 1, 2030. Employment Requirement The Option Award will vest on April 1, 2028, subject to Mr. Mazanderani's continuous employment through this date. Termination of Employment No acceleration of vesting upon termination of employment, death or disability. Change in Control No automatic acceleration of vesting upon a change in control of our company. Exercise Methods Exercise Methods: Cash: exercise price is paid in cash upon exercise of options. Offset: if acceptable to us, through an offset against amounts owed by us to Mr. Mazanderani. Tender of Stock: by tender to us of shares held by Mr. Mazanderani, including shares deliverable upon exercise of the Option Award. Broker-Assisted Cashless Exercise. Net Exercise: via the exercise of all or any vested portion of the Option Award without payment of the Exercise Price in cash, pursuant to which we will issue to Mr. Mazanderani a number of whole Shares determined in accordance with an agreed formula per the Option Agreement. By any other means acceptable to us. A combination of the foregoing. Clawback The Option Award is subject to our clawback policy, as in effect from time to time. The Option Award was previously approved, subject to shareholder approval, by the Board. The summary of the Option Award contained herein is qualified by and subject to the full text of the Option Award, which was included as Appendix A to the 2026 Proxy Statement and is attached as Exhibit 10.1 to this Form 8-K, and which is incorporated herein by reference.
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07. Submission of Matters to a Vote of Security Holders. The following is a summary of the voting results for the proposal presented to shareholders at the Special Meeting held on August 3, 2026. Proposal No. 1-To approve, for purposes of complying with Nasdaq Listing Rule 5635(c), the grant of a share option to Mr. Ali Mazanderani, our Executive Chairman, pursuant to a share option agreement The grant of the Option Award was approved and the votes cast were as follows: Votes cast For Against Abstain 38,334,363 1,241,298 7,796,947

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.